| 000 | 01642 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250511141006.0 | ||
| 264 | 0 | _c19780612 | |
| 008 | 197806s 0 0 eng d | ||
| 022 | _a0031-7012 | ||
| 024 | 7 |
_a10.1159/000136817 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVigouret, J M | |
| 245 | 0 | 0 |
_aNeurochemical and neuropharmacological investigations with four ergot derivatives: bromocriptine, dihydroergotoxine, CF 25-397 and CM 29-712. _h[electronic resource] |
| 260 |
_bPharmacology _c1978 |
||
| 300 |
_a156-73 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
| 650 | 0 | 4 |
_aBrain _xmetabolism |
| 650 | 0 | 4 |
_aBromocriptine _xpharmacology |
| 650 | 0 | 4 |
_aCatecholamines _xmetabolism |
| 650 | 0 | 4 | _aChemical Phenomena |
| 650 | 0 | 4 | _aChemistry |
| 650 | 0 | 4 |
_aDihydroergotoxine _xpharmacology |
| 650 | 0 | 4 | _aElectroencephalography |
| 650 | 0 | 4 |
_aErgolines _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLocomotion _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMorphine _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMovement Disorders _xchemically induced |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptors, Dopamine _xdrug effects |
| 650 | 0 | 4 | _aReserpine |
| 650 | 0 | 4 |
_aSleep _xdrug effects |
| 650 | 0 | 4 |
_aStereotyped Behavior _xdrug effects |
| 700 | 1 | _aBürki, H R | |
| 700 | 1 | _aJaton, A L | |
| 700 | 1 | _aZüger, P E | |
| 700 | 1 | _aLoew, D M | |
| 773 | 0 |
_tPharmacology _gvol. 16 Suppl 1 _gp. 156-73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000136817 _zAvailable from publisher's website |
| 999 |
_c585911 _d585911 |
||